Longitudinal humoral immune response against COVID-19 adenovirus-based vaccines in patients with multiple sclerosis from Argentina undergoing immunosuppressive treatment

被引：0

作者：

Silva, B. A. ^{[1
,2
,3
]}

Miglietta, E. ^{[2
]}

Eizaguirre, B. ^{[1
]}

Alonso, R. ^{[1
]}

Wenker, S. ^{[2
]}

Casabona, J. C. ^{[2
]}

Casas, M. ^{[1
]}

Lazaro, L. ^{[1
]}

Cohen, L. ^{[1
]}

Pita, C. ^{[1
]}

Man, F. ^{[4
]}

Portuondo, G. ^{[4
]}

Bisso, A. Lopez ^{[4
]}

Zabala, N. ^{[4
]}

Casales, F. ^{[5
]}

Imhoff, G. ^{[6
]}

Steinberg, J. ^{[6
]}

Lopez, P. ^{[7
]}

Contentti, E. Carnero ^{[7
]}

Deri, N. ^{[8
]}

Sinay, V. ^{[9
]}

Hryb, J. ^{[10
]}

Chiganer, E. ^{[10
]}

Leguizamon, F. ^{[11
]}

Tkachuk, V. ^{[12
]}

Bauer, J. ^{[13
]}

Giachello, S. ^{[14
]}

Henestroza, P. ^{[14
]}

Garcea, O. ^{[1
]}

Vinzon, S. ^{[15
]}

Podhajcer, O. ^{[15
]}

Pitossi, F. ^{[2
]}

Ferrari, C. ^{[2
]}

机构：

[1] Hosp Ramos Mejia, Ctr Univ Esclerosis Multiple, Buenos Aires, Argentina

[2] Leloir Inst Fdn, Lab Terapias Regenerat Protectoras Sistema, Buenos Aires, Argentina

[3] Hosp Italiano Buenos Aires, Secc Enfermedades Desmielinizantes, Buenos Aires, DF, Argentina

[4] Hosp Ramos Mejia, Serv Neurol, Buenos Aires, DF, Argentina

[5] Sanatorio Arcos, Serv Neurol, Buenos Aires, Argentina

[6] Hosp Britanico, Serv Neuro, Buenos Aires, Argentina

[7] Hosp Aleman, Unidad Neuroinmunol, Buenos Aires, Argentina

[8] DIABAID, Buenos Aires, Argentina

[9] Fdn Favaloro, Buenos Aires, Argentina

[10] Hosp Durand, Consult Neuroinmunol Clin, Buenos Aires, Argentina

[11] Hosp Alvarez, Buenos Aires, Argentina

[12] Hosp Clin Buenos Aires, Clin Enfermedades Desmielinizantes, Buenos Aires, Argentina

[13] Esclerosis Multiple Argentina, Buenos Aires, Argentina

[14] Asociac Lucha Esclerosis Multiple, San Antonio, Argentina

[15] Leloir Inst Fdn, Lab Terapia Mol & Celular, Buenos Aires, Argentina

来源：

MULTIPLE SCLEROSIS JOURNAL | 2022年 / 28卷 / 3_SUPPL期

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

EP1094

引用

页码：868 / 868

页数：1

共 50 条

[1] Do immunosuppressive treatments influence immune responses against adenovirus-based COVID-19 vaccines in patients with multiple sclerosis? An Argentine multicenter study
Silva, Berenice Anabel
Miglietta, Esteban
Casabona, Juan Cruz
Wenker, Shirley
Eizaguirre, Maria Barbara
Alonso, Ricardo
Casas, Magdalena
Lazaro, Luciana Grimanesa
Man, Federico
Portuondo, Gustavo
Bisso, Abril Lopez
Zavala, Noelia
Casales, Federico
Imhoff, Gaston
Steinberg, Dra Judith
Lopez, Pablo Adrian
Contentti, Edgar Carnero
Deri, Norma
Sinay, Vladimiro
Hryb, Javier
Chiganer, Edson
Leguizamon, Felisa
Tkachuk, Veronica
Bauer, Johana
Ferrandina, Flavia
Giachello, Susana
Henestroza, Paula
Garcea, Orlando
Pascuale, Carla Antonela
Heitrich, Mauro
Podhajcer, Osvaldo L.
Vinzon, Sabrina
D'Alotto-Moreno, Tomas
Benatar, Alejandro
Rabinovich, Gabriel Adrian
Pitossi, Fernando J.
Ferrari, Carina C.
FRONTIERS IN IMMUNOLOGY, 2024, 15
[2] Analysis of Host Immunological Response of Adenovirus-Based COVID-19 Vaccines
Farhang-Sardroodi, Suzan
Korosec, Chapin S.
Gholami, Samaneh
Craig, Morgan
Moyles, Iain R.
Ghaemi, Mohammad Sajjad
Ooi, Hsu Kiang
Heffernan, Jane M.
VACCINES, 2021, 9 (08)
[3] Humoral immune response to COVID-19 mRNA vaccines in patients with relapsing multiple sclerosis treated with ofatumumab
Bar-Or, Amit
Aburashed, Rany
Chinea, Angel R.
Hendin, Barry A.
Lucassen, Elisabeth
Meng, Xiangyi
Stankiewicz, James
Tullman, Mark J.
Cross, Anne H.
MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2023, 79
[4] Humoral immune response to COVID-19 mRNA vaccines in patients with relapsing multiple sclerosis treated with ofatumumab
Hendin, B. A.
Cross, A. H.
Chinea, A. R.
Tullman, M. J.
Aburashed, R.
Stankiewicz, J.
Lucassen, E.
Meng, X.
Bar-Or, A.
MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 367 - 367
[5] Assessment of humoral immune response to different COVID-19 vaccines in patients undergoing maintenance hemodialysis
Abd El-Hameed, Ayman
Ahmed, Mohammed Fouad
Ehmemeed, Ali Omar Ahmed
Mokhtar, Ahmad
Abdelhamid, Walid Ahmed Ragab
JORNAL BRASILEIRO DE NEFROLOGIA, 2023, 45 (04): : 417 - 423
[6] Differences in neutralization of SARS-Cov-2 Omicron and Wuhan variants and cellular immune response to adenovirus-based Covid-19 vaccines in people with Multiple Sclerosis from LatinAmerica
Silva, Berenice
Casabona, Juan Cruz
Miglietta, Esteban
Wenker, Shirley
Alonso, Ricardo Nicolas
Eizaguirre, Maria Barbara
Casas, Magdalena
Lazaro, Luciana
Cohen, Leila
Pita, Cecilia
Man, Federico
Portuondo, Gustavo
Bisso, Abril Lopez
Zavala, Noelia
Casales, Federico
Steinberg, Judith
Lopez, Pablo Adrian
Contentti, Edgar German Carnero
Deri, Norma
Sinay, Vladimiro Joaquin
Hryb, Javier
Chiganer, Edson
Leguizamon, Felisa
Tkachuk, Veronica Analia
Bauer, Johana Julia
Henestroza, Paula
Giachello, Susana
Garcea, Domingo Orlando
Podhajcer, Osvaldo
Rabinovich, Gabriel
Pitossi, Fernando
Vinzon, Sabrina
Ferrari, Carina
MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 362 - 362
[7] Humoral immune response to COVID-19 vaccines in people with secondary progressive multiple sclerosis treated with siponimod
Skoric, Magdalena Krbot
Rogic, Dunja
Lapic, Ivana
Segulja, Dragana
Habek, Mario
MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 57
[8] COVID-19 vaccination and humoral immune response in people with multiple sclerosis
Oreja-Guevara, C.
Ramirez, C. I.
Alba-Suarez, E.
Gomez-Estevez, I.
Bullon-Sanchez, C.
Castro-Hernandez, M.
Martinez-Perez, E.
Diaz-Diaz, J.
MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 728 - 728
[9] Humoral response to SARS-CoV-2 COVID-19 vaccines in patients with multiple sclerosis treated with immune reconstitution therapies
Drulovic, Jelena
Ivanovic, Jovana
Martinovic, Vanja
Tamas, Olivera
Veselinovic, Nikola
Cujic, Danica
Gnjatovic, Marija
Mesaros, Sarlota
Pekmezovic, Tatjana
MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 54
[10] Evaluation of the Durability of the Immune Humoral Response to COVID-19 Vaccines in Patients With Cancer Undergoing Treatment or Who Received a Stem Cell Transplant RESPONSE
Grimes, David Robert
JAMA ONCOLOGY, 2022,

← 1 2 3 4 5 →